{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:17:00Z","timestamp":1770833820344,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.semnephrol.2011.11.006","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T22:19:24Z","timestamp":1330035564000},"page":"40-48","source":"Crossref","is-referenced-by-count":29,"title":["Cardio-Renal Syndrome Type 4: Epidemiology, Pathophysiology and Treatment"],"prefix":"10.1016","volume":"32","author":[{"given":"Andrew A.","family":"House","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2011.11.006_bib2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2010.03.019","article-title":"Cardiovascular disease and CKD: core curriculum 2010","volume":"56","author":"Shastri","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfq066","article-title":"Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"Bagshaw","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib6","first-page":"351291","article-title":"Heart-kidney interaction: epidemiology of cardio-renal syndromes","volume":"2011","author":"Cruz","year":"2010","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1046\/j.1523-1755.2002.00270.x","article-title":"Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2010.03.019","article-title":"Cardiovascular disease and CKD: core curriculum 2010","volume":"56","author":"Shastri","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/17.1.7","article-title":"Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome?","volume":"17","author":"Herzog","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ehj.2004.08.016","article-title":"Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials","volume":"25","author":"Gibson","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","article-title":"The prognostic importance of left ventricular geometry in uremic cardiomyopathy","volume":"5","author":"Foley","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrneph.2010.191","article-title":"Medscape: sudden cardiac death in chronic kidney disease: epidemiology and prevention","volume":"7","author":"Shamseddin","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2009.219","article-title":"Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease","volume":"76","author":"Pun","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/08860220802212908","article-title":"Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias","volume":"30","author":"Burton","year":"2008","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardio-Renal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1681\/ASN.2005091012","article-title":"Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial","volume":"17","author":"Ishani","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000441-200610000-00006","article-title":"Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice","volume":"332","author":"Parikh","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1309\/M7AAXA0J1THMNCDF","article-title":"Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease","volume":"126","author":"Austin","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/gfq647","article-title":"Biomarkers in kidney and heart disease","volume":"26","author":"Maisel","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib32","first-page":"11","article-title":"New markers of accelerated atherosclerosis in end-stage renal disease","volume":"16","author":"Rattazzi","year":"2003","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","article-title":"Inflammation in end-stage renal disease: the hidden enemy","volume":"11","author":"Stenvinkel","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.0000127577.63323.24","article-title":"C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease","volume":"109","author":"Verma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.mehy.2005.07.001","article-title":"Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition","volume":"65","author":"Zsuga","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/ndt\/gfq862","article-title":"Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD","volume":"26","author":"Olgaard","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/089686080702700502","article-title":"Assessing plasma total homocysteine in patients with end-stage renal disease","volume":"27","author":"Urquhart","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib39","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-9150(01)00502-0","article-title":"Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate","volume":"159","author":"Bostom","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1523-1755.2004.00736.x","article-title":"Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein","volume":"66","author":"Busch","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib42","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1046\/j.1523-1755.2002.00658.x","article-title":"Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS","volume":"62","author":"Pifer","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMra071313","article-title":"Uremia","volume":"357","author":"Meyer","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1523-1755.2005.09906.x","article-title":"Chronic renal failure: a cardiovascular risk factor","volume":"99","author":"Fort","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/ajkd.1998.v32.pm9669431","article-title":"Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients","volume":"32","author":"Bologa","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/152308602762197470","article-title":"Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease","volume":"4","author":"Wratten","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ndt\/gfh052","article-title":"Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients","volume":"19","author":"Panichi","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 8","key":"10.1016\/j.semnephrol.2011.11.006_bib52","first-page":"S87","article-title":"Long-term outcome in hemodialysis: morbidity and mortality","author":"Pozzoni","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib53","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1046\/j.1523-1755.63.s85.25.x","article-title":"Traditional and emerging cardiovascular risk factors in end-stage renal disease","volume":"85","author":"Zoccali","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1755.61.s80.19.x","article-title":"Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?","volume":"80","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib55","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib56","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2004.01.016","article-title":"Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms","volume":"43","author":"MacRae","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib57","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2215\/CJN.03080410","article-title":"Determinants of cardiac autonomic dysfunction in ESRD","volume":"5","author":"Chan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.0894-0959.2004.17360.x","article-title":"Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary","volume":"17","author":"Culleton","year":"2004","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib61","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib62","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib63","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMc076523","article-title":"The normal hematocrit study\u2014follow-up","volume":"358","author":"Besarab","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ASN.0000110181.64655.6C","article-title":"Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease","volume":"15","author":"Wrone","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib67","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.ajkd.2006.10.002","article-title":"The effect of mesna on plasma total homocysteine concentration in hemodialysis patients","volume":"49","author":"Urquhart","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib69","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.2010.490","article-title":"Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial","volume":"303","author":"House","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib70","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2011.11.006_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2006.01663.x","article-title":"Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease","volume":"36","author":"Mathew","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006023.pub2","article-title":"Phosphate binders for preventing and treating bone disease in chronic kidney disease patients","volume":"2","author":"Navaneethan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib73","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib74","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11180","article-title":"The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation","volume":"11","author":"Garside","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib75","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib77","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib78","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mam.2008.04.001","article-title":"Vitamin D analogs: therapeutic applications and mechanisms for selectivity","volume":"29","author":"Brown","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jrn.2006.07.006","article-title":"Impact of kidney bone disease and its management on survival of patients on dialysis","volume":"17","author":"Lee","year":"2007","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1440-1797.2009.01151.x","article-title":"Weighing the evidence for treatment of chronic kidney disease mineral and bone disorder","volume":"14","author":"Navaneethan","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib81","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib82","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"issue":"9784","key":"10.1016\/j.semnephrol.2011.11.006_bib83","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib84","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week","volume":"363","author":"Chertow","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.11.006_bib85","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511001859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T18:00:16Z","timestamp":1640887216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929511001859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0270929511001859"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2011.11.006","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}